Ha Tay Pharmaceutical JSC
Ha Tay Pharmaceutical JSC, commonly referred to as Ha Tay Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1976, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions in Vietnam. Specialising in the development of generic medicines, Ha Tay Pharma offers a diverse range of products, including tablets, capsules, and injectables, distinguished by their adherence to stringent quality standards. The company has achieved notable milestones, including certifications that affirm its commitment to excellence in manufacturing practices. With a strong market presence, Ha Tay Pharmaceutical JSC is recognised for its innovative approach and dedication to improving healthcare outcomes, positioning itself as a trusted name in the Vietnamese pharmaceutical landscape.
DitchCarbon Score
How does Ha Tay Pharmaceutical JSC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ha Tay Pharmaceutical JSC's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ha Tay Pharmaceutical JSC's reported carbon emissions
Ha Tay Pharmaceutical JSC, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that Ha Tay Pharmaceutical JSC may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Ha Tay Pharmaceutical JSC to consider setting measurable targets and participating in recognised climate initiatives to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ha Tay Pharmaceutical JSC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
